![]() |
|
|
Vol. 299, Issue 1, 76-82, October 2001
AstraZeneca R&D Mölndal, Mölndal, Sweden
Oxidation of lipoprotein-derived lipids is generally accepted to be
important in atherogenesis, and lipophilic antioxidants have been
suggested as potential antiatherosclerotic agents. The antiatherogenic
effects observed by certain antioxidants, especially probucol, in
different animal models support this suggestion. There are however also
cases where other lipophilic antioxidants have not been able to support
this hypothesis. This has raised the question whether the effects of
probucol and similar compounds are mainly due to some other property,
unrelated to their antioxidant efficacy. For example, probucol is shown
to possess immunomodulatory properties. Immune reactions are known to
occur during atherogenesis. We therefore tested the dimer of
N-acetylcysteine, DiNAC, which is a disulfide with
immunomodulating properties and enhances oxazolone-induced contact
sensitivity (CS) reactions in mice, for effects on atherosclerosis. When given to male heritable hyperlipidemic rabbit (WHHL) rabbits from
10 to 22 weeks of age, this compound reduced by 50% thoracic aorta
atherosclerosis (p < 0.05), without affecting
plasma lipid levels. Here we also show that probucol and a close
chemical analog, both known to prevent atherosclerosis in WHHL rabbits,
enhance the CS reaction in mice, while two other related antioxidants did not affect the CS reaction. At least one of these is also without
effect on atherosclerosis in WHHL rabbits. The results show that DiNAC
might represent a new treatment modality for atherosclerosis-related disease, and suggest that some antioxidants may have
antiatherosclerotic properties more related to "immunomodulatory"
properties than to antioxidant properties in general.